Target intelligence / Profile preview

Mitochondrial quality control and dynamics machinery (MQC)

Target
MQC
Molecular classification
Enzyme, GTPase, Kinase, Ubiquitin ligase, Receptor, Chaperone
01

Overview

The mitochondrial quality control and dynamics machinery is a multi-layered system essential for preserving mitochondrial integrity and cellular homeostasis. It operates through a balance of mitochondrial fission, mediated by proteins like Dynamin-related protein 1 (DRP1), and fusion, governed by Mitofusins (MFN1/2) and Optic atrophy 1 (OPA1) (PubMed). When mitochondria become damaged beyond repair, the machinery initiates mitophagy—a specialized form of autophagy—primarily through the PINK1/Parkin signaling pathway to ensure the removal of dysfunctional organelles (UniProt). Impairment of these regulatory mechanisms is strongly linked to the pathogenesis of neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes, as it leads to the accumulation of defective mitochondria and increased reactive oxygen species (NIH). Pharmacological intervention focuses on modulating these dynamic processes, such as using DRP1 inhibitors to prevent excessive fragmentation or mitophagy enhancers to clear damaged mitochondria, offering a promising therapeutic avenue for age-related and metabolic diseases (Nature Reviews Drug Discovery).

Other names
Mitochondrial quality control systemMitochondrial dynamics and mitophagy pathwayMitochondrial proteostasis and dynamics
02

Mechanism of action

Modulation of mitochondrial fission and fusion proteins (e.g., DRP1 inhibition, MFN activation), induction of mitophagy via PINK1/Parkin or receptor-mediated pathways, and enhancement of mitochondrial proteostasis through chaperone and protease activation.

03

Biological functions

MitophagyMitochondrial fissionMitochondrial fusionMitochondrial proteostasisMitochondrial biogenesisApoptosis regulation
04

Disease associations

Parkinson's diseaseAlzheimer's diseaseHuntington's diseaseAmyotrophic lateral sclerosisCardiovascular diseaseType 2 diabetesCancer
05

Safety considerations

Potential for systemic mitochondrial toxicityDisruption of essential energy metabolism in non-target tissuesRisk of inducing unintended apoptosisComplexity of targeting dynamic protein-protein interactions
06

Interacting drugs

Mdivi-1

6 more in the full profile.

07

Biomarkers

Mitochondrial DNA (mtDNA) copy numberDRP1 phosphorylation statusPINK1/Parkin protein levelsMitophagy flux (e.g., LC3-II/I ratio on mitochondria)Mitochondrial membrane potential

Beyond the preview

Go deeper on Mitochondrial quality control and dynamics machinery (MQC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial quality control and dynamics machinery (MQC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call